Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ursodeoxycholic acid adverse reaction |
Causative agent (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ursodeoxycholic acid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ursodeoxycholic acid 250mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urosodiol 150mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ursodeoxycholic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chenodeoxycholic acid and ursodeoxycholic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chenodeoxycholic and ursodeoxycholic acid adverse reaction |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ursodeoxycholic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ursodeoxycholic acid 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Ursodeoxycholic acid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urosodiol 150mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urosodiol 150mg tablet |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 300 mg oral tablet |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urosodiol 150mg tablet |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chenodeoxycholic acid and ursodeoxycholic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ursodeoxycholic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ursodeoxycholic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |